Reporting to the Director, Product Management – Cloud Platforms, the Product Manager will be responsible for developing and commercializing new cloud and data capabilities for internal and partner Data Management Platforms. The successful leader will have experience leading end-to-end product management for global connected products, with the ability to translate business goals into high-impact product initiatives. Informed by a deep understanding of customer needs, competitive dynamics in the market, and technology constraints and opportunities, they will develop and lead the execution of a roadmap that positions Insulet for sustained market leadership. They will achieve this by cultivating empowered, high-impact teams, and guiding teams through discovery, viability, execution, and in-market optimization, providing strong cross-functional leadership. They will develop and own business cases for product initiatives and work cross-functionally to deliver market-beating products on-time and on-budget, to advance Insulet’s mission to improve the lives of people with diabetes. Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable and waterproof Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero finger sticks, and is fully controlled by a compatible personal smartphone. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. Studies have demonstrated the clinical and lifestyle advantages of insulin pump therapy over multiple daily insulin injections (MDI). However, many people still choose MDI therapy largely due to the complexity, cost, and inconvenience of conventional pump technology. The Omnipod is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. By breaking down the barriers to insulin pump therapy, Insulet hopes to provide both a superior treatment option and life-long health benefits for people with insulin-requiring diabetes. Insulet was founded in 2000 with the mission to improve the lives of people with diabetes and enable customers to enjoy simplicity, freedom, and healthier lives through innovative technology. The Company’s world headquarters and state-of-the-art automated manufacturing facility are located in Acton, Massachusetts with global offices in the U.K., France, Germany, Netherlands, Canada, Mexico, Australia, and the United Arab Emirates. Omnipod products are available in 24 countries around the world. Insulet recently concluded its seventh consecutive year of 20% or more revenue growth, and more than doubled its intellectual property portfolio over the last year. Insulet is proud to be recognized as a 2022 Top Workplace USA; awarded Top Workplaces Cultural Excellence Award for remote work; recognized as a Great Place to Work® in four international locations in 2023; and ranked as one of America’s most responsible companies by Newsweek. For more information, visit: insulet.com and omnipod.com.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
No Education Listed